Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

4.

Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II.

Wessells H, Levine N, Hadley ME, Dorr R, Hruby V.

Int J Impot Res. 2000 Oct;12 Suppl 4:S74-9.

PMID:
11035391
5.

Salvage of sildenafil failures with bremelanotide: a randomized, double-blind, placebo controlled study.

Safarinejad MR, Hosseini SY.

J Urol. 2008 Mar;179(3):1066-71. doi: 10.1016/j.juro.2007.10.063.

PMID:
18206919
6.

PT-141: a melanocortin agonist for the treatment of sexual dysfunction.

Molinoff PB, Shadiack AM, Earle D, Diamond LE, Quon CY.

Ann N Y Acad Sci. 2003 Jun;994:96-102.

PMID:
12851303
7.

Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study.

Wessells H, Fuciarelli K, Hansen J, Hadley ME, Hruby VJ, Dorr R, Levine N.

J Urol. 1998 Aug;160(2):389-93.

PMID:
9679884
8.

Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction.

Wessells H, Gralnek D, Dorr R, Hruby VJ, Hadley ME, Levine N.

Urology. 2000 Oct 1;56(4):641-6.

PMID:
11018622
9.

A phase II, single-blind, randomized, crossover evaluation of the safety and efficacy of avanafil using visual sexual stimulation in patients with mild to moderate erectile dysfunction.

Hellstrom WJ, Freier MT, Serefoglu EC, Lewis RW, DiDonato K, Peterson CA.

BJU Int. 2013 Jan;111(1):137-47. doi: 10.1111/j.1464-410X.2012.11267.x.

10.

Effects of oral phentolamine, taken before sleep, on nocturnal erectile activity: a double-blind, placebo-controlled, crossover study.

Hatzichristou DG, Apostolidis A, Tzortzis V, Hatzimouratidis K, Kouvelas D.

Int J Impot Res. 2001 Oct;13(5):303-8.

PMID:
11890519
11.

Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.

Skoumal R, Chen J, Kula K, Breza J, Calomfirescu N, Basson BR, Kopernicky V.

Eur Urol. 2004 Sep;46(3):362-9; discussion 369.

PMID:
15306109
12.

Erectile response to vardenafil in men with a history of nonresponse to sildenafil: a time-from-dosing descriptive analysis.

Hatzichristou DG, Aliotta P, Auerbach S, Barkin J, Lording D, Murdock M, Wilkins HJ, McBride TA, Colopy MW, Carson CC; Patient Response with Vardenafil in Sildenafil Non-Responders (PROVEN) Study Group..

Clin Ther. 2005 Sep;27(9):1452-61.

PMID:
16291418
13.

Vasomax for the treatment of male erectile dysfunction.

Goldstein I, Carson C, Rosen R, Islam A.

World J Urol. 2001 Feb;19(1):51-6.

PMID:
11289571
14.

Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.

Eardley I, Gentile V, Austoni E, Hackett G, Lembo D, Wang C, Beardsworth A.

BJU Int. 2004 Oct;94(6):871-7.

15.

Pilot study of the endothelin-A receptor selective antagonist BMS-193884 for the treatment of erectile dysfunction.

Kim NN, Dhir V, Azadzoi KM, Traish AM, Flaherty E, Goldstein I.

J Androl. 2002 Jan-Feb;23(1):76-83.

16.

Efficacy and safety of tadalafil 5, 10, and 20 mg in Japanese men with erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled study.

Nagao K, Kimoto Y, Marumo K, Tsujimura A, Vail GM, Watts S, Ishii N, Kamidono S.

Urology. 2006 Oct;68(4):845-51.

PMID:
17070365
17.

Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers.

Carson C, Shabsigh R, Segal S, Murphy A, Fredlund P, Kuepfer C; Trial Evaluating the Activity of Tadalafil for Erectile Dysfunction-United States (TREATED-US) Study Group..

Urology. 2005 Feb;65(2):353-9.

PMID:
15708052
18.

Efficacy and safety of oral SK3530 for the treatment of erectile dysfunction in Korean men: a multicenter, randomized, double-blind, placebo-controlled, fixed dose, parallel group clinical trial.

Paick JS, Choi HK, Kim SC, Ahn TY, Kim JJ, Park JK, Park KS, Lee SW, Kim SW, Park K, Jung H, Park NC.

Asian J Androl. 2008 Sep;10(5):791-8. doi: 10.1111/j.1745-7262.2008.00422.x.

19.

Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.

Bergman AJ, Stevens C, Zhou Y, Yi B, Laethem M, De Smet M, Snyder K, Hilliard D, Tanaka W, Zeng W, Tanen M, Wang AQ, Chen L, Winchell G, Davies MJ, Ramael S, Wagner JA, Herman GA.

Clin Ther. 2006 Jan;28(1):55-72.

PMID:
16490580
Items per page

Supplemental Content

Support Center